Select Medical (NYSE:SEM) Stock Price Crosses Above Two Hundred Day Moving Average – What’s Next?

Select Medical Holdings Corporation (NYSE:SEM) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $14.85 and traded as high as $16.41. Select Medical shares last traded at $16.3450, with a volume of 1,687,654 shares trading hands.

Analyst Upgrades and Downgrades

SEM has been the subject of several research analyst reports. Wall Street Zen downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, March 9th. Benchmark lowered Select Medical from a “buy” rating to a “hold” rating in a report on Wednesday, March 4th. Zacks Research lowered Select Medical from a “hold” rating to a “strong sell” rating in a report on Thursday, February 26th. Royal Bank Of Canada reissued a “sector perform” rating and set a $16.50 price target (down from $19.00) on shares of Select Medical in a report on Tuesday, March 3rd. Finally, Weiss Ratings raised Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, February 20th. Two research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $15.63.

Select Medical Stock Performance

The company has a debt-to-equity ratio of 0.89, a current ratio of 1.04 and a quick ratio of 1.04. The stock has a market cap of $2.03 billion, a price-to-earnings ratio of 14.21, a P/E/G ratio of 0.94 and a beta of 1.12. The stock’s 50-day moving average is $15.93 and its 200 day moving average is $14.85.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, February 19th. The health services provider reported $0.16 EPS for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.07). The firm had revenue of $1.40 billion during the quarter, compared to analyst estimates of $1.36 billion. Select Medical had a net margin of 2.68% and a return on equity of 7.26%. Select Medical’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.18 EPS. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. As a group, analysts predict that Select Medical Holdings Corporation will post 1.17 earnings per share for the current fiscal year.

Select Medical Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 12th. Investors of record on Monday, March 2nd were given a $0.0625 dividend. The ex-dividend date was Monday, March 2nd. This represents a $0.25 dividend on an annualized basis and a yield of 1.5%. Select Medical’s dividend payout ratio (DPR) is presently 21.74%.

Select Medical announced that its Board of Directors has approved a share buyback plan on Thursday, February 19th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the health services provider to reacquire up to 49.5% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s leadership believes its shares are undervalued.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Hsbc Holdings PLC increased its holdings in Select Medical by 4.9% in the fourth quarter. Hsbc Holdings PLC now owns 29,331 shares of the health services provider’s stock valued at $436,000 after buying an additional 1,364 shares in the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in Select Medical in the fourth quarter valued at about $28,000. Beartown Capital Management LLC purchased a new position in Select Medical in the fourth quarter valued at about $2,970,000. State of Tennessee Department of Treasury increased its holdings in Select Medical by 33.2% in the fourth quarter. State of Tennessee Department of Treasury now owns 63,307 shares of the health services provider’s stock valued at $953,000 after buying an additional 15,787 shares in the last quarter. Finally, XTX Topco Ltd increased its holdings in Select Medical by 394.2% in the fourth quarter. XTX Topco Ltd now owns 138,229 shares of the health services provider’s stock valued at $2,053,000 after buying an additional 110,257 shares in the last quarter. 89.48% of the stock is owned by hedge funds and other institutional investors.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.